June 2026 Research Update

These case reports add detail to how varied T-cell large granular lymphocytic leukemia (T-LGLL) can look in real life, especially when the main problem is low blood counts. The shared message is that T-LGLL may appear alongside other bone marrow and blood conditions, and it can have unusual lab or microscope findings that might confuse the diagnosis at first. [1] [2]

One report described a rare T-LGLL subtype (TCR gamma-delta positive) that appeared together with severe aplastic anemia and a paroxysmal nocturnal hemoglobinuria (PNH) clone. The authors suggested that T-cells suppressing normal blood formation could help explain why these conditions showed up together in this person. [1]

Another report described a person with cytopenias and an enlarged spleen who had a clonal CD8+ T-cell population with a STAT3 mutation, which is a change sometimes seen in T-LGLL. The report also noted a rare Auer rod-like inclusion inside the leukemia cells that was myeloperoxidase-negative, an unusual finding that could resemble changes more typical of other blood cancers. [2]

For patients and caregivers, this month mainly adds understanding rather than changing care right now, because the evidence comes from single-patient reports. It helps clarify why diagnosing T-LGLL can sometimes take time when severe low blood counts are present, and why doctors may look for overlapping conditions like aplastic anemia or a PNH clone in selected situations. What remains uncertain is how often these rare patterns happen and whether they predict a similar course in other people. [1] [2]

This month included one unusual report where T-LGLL improved in a person who was receiving sildenafil for pulmonary hypertension. Because it is only one person and sildenafil was not given as a leukemia treatment, the report should be read as an observation that raises questions rather than a confirmed approach. [3]

The case described regression of T-LGLL during sildenafil therapy, without providing broader evidence about how common this is. The report does not establish whether sildenafil caused the regression, but it points to a possible link worth studying more carefully in larger groups. [3]

For patients, this finding is early research and does not show that sildenafil is a proven treatment for T-LGLL. Its value right now is mainly in showing that unexpected changes in T-LGLL can sometimes be noticed when someone starts or uses a medicine for another condition. What remains uncertain is whether this was a coincidence or something that could repeat in other patients. [3]